Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Junshi Biosciences Secures Approval for Toripalimab (LOQTORZI®) for Nasopharyngeal Carcinoma

Thursday, March 27, 2025

Junshi Biosciences has received approval from the Singapore Health Sciences Authority HSA for toripalimab marketed as LOQTORZI in Singapore Nasopharyngeal carcinoma is a malignant tumour that originates in the epithelial mucosa of the nasopharynx and...

Exelixis Secures FDA Approval for CABOMETYX® in Advanced Neuroendocrine Tumours

Thursday, March 27, 2025

Exelixis has announced that the United States Food and Drug Administration FDA has approved CABOMETYX cabozantinib for the treatment of adult and paediatric patients aged years and older with previously treated unresectable

GV20 Therapeutics Enters into Collaboration with Mitsubishi Tanabe Pharma to Develop Antibody-Drug Conjugates

Thursday, March 27, 2025

GV Therapeutics has entered into a research collaboration with Mitsubishi Tanabe Pharma Corporation AntibodyDrug Conjugates ADCs are a class of targeted cancer therapies that combine

MSD Enters into Agreement with Hengrui Pharma for HRS-5346, an Investigational Lipoprotein(a) Inhibitor

Wednesday, March 26, 2025

MSD has entered into an exclusive licence agreement with Jiangsu Hengrui Pharmaceuticals for HRS an investigational oral small molecule inhibitor targeting Lipoproteina Lpa

Porosome Therapeutics Unveils Breakthrough in Alzheimer’s Disease Research

Wednesday, March 26, 2025

Porosome Therapeutics has announced a significant breakthrough in Alzheimers disease research focusing on secretory dysfunction and new therapeutic approaches Alzheimers disease is characterised by neuronal loss due to secretory and metabolic defects...

Kelun-Biotech’s Radionuclide-Drug Conjugate SKB107 Receives Approval for Bone Metastases Treatment

Wednesday, March 26, 2025

Sichuan KelunBiotech Biopharmaceutical has received approval from Chinas National Medical Products Administration NMPA to conduct clinical trials for SKB a radionuclidedrug conjugate RDC developed for treating bone metastases in solid tumors

SineuGene Therapeutics Receives Clearance on SNUG01 for Gene Therapy Targeting Amyotrophic Lateral Sclerosis (ALS) Treatment

Tuesday, March 25, 2025

SineuGene Therapeutics has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for SNUG a gene therapy candidate targeting TRIM Tripartite Motif Protein for the treatment of amyotrophic la...

Everest Medicines Receives FDA Clearance for Investigational Cancer Vaccine EVM14

Monday, March 24, 2025

Everest Medicines has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for EVM Lung cancer remains one of the most prevalent cancers worldwide with nearly million new cases reported ann...

Novo Nordisk and The United Laboratories International Holdings Limited (TUL) Agreement to Develop UBT251 for Metabolic Disorders

Monday, March 24, 2025

Novo Nordisk and The United Laboratories International Holdings Limited TUL have entered into an exclusive licence agreement for UBT a triple receptor agonist targeting GLP GIP and glucagon

Alnylam Secures FDA Approval for AMVUTTRA® (vutrisiran) in Treating Cardiomyopathy

Friday, March 21, 2025

Alnylam Pharmaceuticals has received approval from the US Food and Drug Administration FDA for its RNAibased treatment AMVUTTRA vutrisiran ATTRCM is a severe and rapidly progressing condition that affects approximately people in the United States an...